Javdat N. Muratkhodjaev
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Javdat N. Muratkhodjaev has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Tamara Aripova
Institute of Immunology and Human Genomics Academy of Sciences of Uzbekistan
3 shared publicationsOleg V. Krasilnikov
Institute of Physiology and Biophysics, Academy of Sciences, Tashkent, Uzbekistan
2 shared publications- Tamara Aripova
Institute of Immunology and Human Genomics, Academy of Sciences of the Republic of Uzbekistan, Tashkent
2 shared publications A.O. Zitzer
Middle Asian Antiplague Research Institute, Alma-Ata, Kazakhstan
1 shared publicationA.V. Li
Institute of Molecular Biology and Biochemistry, Alma-Ata, Kazakhstan
1 shared publicationAlexander O. Zitzer
1 shared publication
Latest Publications
- Open Access
- 22 December 2025
- Published by IMR Press in International Journal of Pharmacology
- Vol. 21 (8)
Vascular Dysfunction in Cardiac Cachexia: Molecular Mechanisms and Pharmacotherapies
Severe heart failure (HF) is accompanied by cardiac cachexia (CC), defined as significant weight loss, muscle atrophy, and metabolic abnormalities. Muscle wasting in patients with CC is closely associated with hormonal changes. Previous studies on the pathogenesis of CC have focused on the imbalance between catabolic and anabolic processes. Thus, this review focused on the role of endothelial dysfunction in CC. We summarized how inflammatory cytokines and neurohormonal factors cause vascular dysfunction, leading to reduced nutrient delivery and perfusion. Furthermore, we discuss both conventional and emerging therapeutic strategies that may ameliorate CC by targeting the vasculature. These include ghrelin, the vascular benefits of foundational HF drugs (angiotensin-converting enzyme inhibitors (ACEIs), angiotensin receptor-neprilysin inhibitors (ARNIs), and beta-blockers), and the promise of novel agents, such as BTB and CNC homology 1 (BACH1) inhibitors and fibroblast growth factor 21 (FGF21) agonists. We also summarize the existing animal models of CC and discuss advanced imaging and omics technologies for future research. This review provides a novel perspective on CC pathogenesis and highlights promising avenues for therapeutic intervention.
- 22 December 2025
- Published by IMR Press in International Journal of Pharmacology
- Vol. 21 (8)
Open AccessVascular Dysfunction in Cardiac Cachexia: Molecular Mechanisms and Pharmacotherapies
Severe heart failure (HF) is accompanied by cardiac cachexia (CC), defined as significant weight loss, muscle atrophy, and metabolic abnormalities. Muscle wasting in patients with CC is closely associated with hormonal changes. Previous studies on the pathogenesis of CC have focused on the imbalance between catabolic and anabolic processes. Thus, this review focused on the role of endothelial dysfunction in CC. We summarized how inflammatory cytokines and neurohormonal factors cause vascular dysfunction, leading to reduced nutrient delivery and perfusion. Furthermore, we discuss both conventional and emerging therapeutic strategies that may ameliorate CC by targeting the vasculature. These include ghrelin, the vascular benefits of foundational HF drugs (angiotensin-converting enzyme inhibitors (ACEIs), angiotensin receptor-neprilysin inhibitors (ARNIs), and beta-blockers), and the promise of novel agents, such as BTB and CNC homology 1 (BACH1) inhibitors and fibroblast growth factor 21 (FGF21) agonists. We also summarize the existing animal models of CC and discuss advanced imaging and omics technologies for future research. This review provides a novel perspective on CC pathogenesis and highlights promising avenues for therapeutic intervention.
- Open Access
- 25 September 2025
- Published by Ant Publishing in Aging Pathobiology and Therapeutics
- Vol. 7 (3) , 196-205
Experimental confirmation of osteoarthritis repair in vivo using epigenetic reprogramming with small molecules
Experimental confirmation of osteoarthritis repair in vivo using epigenetic reprogramming with small molecules
- 25 September 2025
- Published by Ant Publishing in Aging Pathobiology and Therapeutics
- Vol. 7 (3) , 196-205
Open AccessExperimental confirmation of osteoarthritis repair in vivo using epigenetic reprogramming with small molecules
Experimental confirmation of osteoarthritis repair in vivo using epigenetic reprogramming with small molecules
- Open Access
Experimental Confirmation of Osteoarthritis Repair In Vivo Using Epigenetic Reprogramming with Small Chemical Molecules
Osteoarthritis (OA) is a progressive degenerative joint disease that significantly impairs mobility and quality of life, particularly in aging populations. Current therapeutic approaches primarily focus on symptom relief, but fail to address the underlying mechanisms of cartilage degeneration. In recent years, epigenetic reprogramming has emerged as a promising strategy for cellular rejuvenation, offering new perspectives for regenerative medicine. This study investigates the potential of a selected set of small chemical molecules (SCM) to induce epigenetic reprogramming of chondrocytes and promote cartilage regeneration in an in vivo model of chemically induced OA. The experiments were conducted on aging female rats, a translational model chosen for its relevance to human age-related OA and postmenopausal cartilage deterioration. OA was induced via intra-articular administration of trypsin, and a subset of animals was further subjected to estrogen receptor blockade using clomiphene citrate to simulate postmenopausal conditions. The SCM cocktail was administered intra-articularly to evaluate its effects on cartilage repair. Chondroitin sulfate was used as a comparative treatment control. The results demonstrated that SCM administration led to significant improvements in joint tissue integrity, including increased cartilage thickness, enhanced synthesis of mucopolysaccharides, and restoration of chondrocyte metabolic activity. Histological analysis revealed that SCM-treated groups exhibited reduced cartilage erosion, lower inflammatory marker expression, and improved nuclear-cytoplasmic index (NCI) values, suggesting enhanced chondrocyte function. Notably, the group with estrogen receptor blockade responded more favorably to SCM treatment than the non-blocked OA group, highlighting the potential interaction between hormonal status and epigenetic reprogramming. These findings provide strong evidence for the feasibility of epigenetic modulation as a therapeutic strategy for OA. The ability of SCMs to restore cartilage structure and function suggests a novel approach to treating age-related degenerative diseases. Further research is required to elucidate the precise molecular mechanisms underlying this rejuvenation process and optimize therapeutic protocols for clinical applications.
Open AccessExperimental Confirmation of Osteoarthritis Repair In Vivo Using Epigenetic Reprogramming with Small Chemical Molecules
Osteoarthritis (OA) is a progressive degenerative joint disease that significantly impairs mobility and quality of life, particularly in aging populations. Current therapeutic approaches primarily focus on symptom relief, but fail to address the underlying mechanisms of cartilage degeneration. In recent years, epigenetic reprogramming has emerged as a promising strategy for cellular rejuvenation, offering new perspectives for regenerative medicine. This study investigates the potential of a selected set of small chemical molecules (SCM) to induce epigenetic reprogramming of chondrocytes and promote cartilage regeneration in an in vivo model of chemically induced OA. The experiments were conducted on aging female rats, a translational model chosen for its relevance to human age-related OA and postmenopausal cartilage deterioration. OA was induced via intra-articular administration of trypsin, and a subset of animals was further subjected to estrogen receptor blockade using clomiphene citrate to simulate postmenopausal conditions. The SCM cocktail was administered intra-articularly to evaluate its effects on cartilage repair. Chondroitin sulfate was used as a comparative treatment control. The results demonstrated that SCM administration led to significant improvements in joint tissue integrity, including increased cartilage thickness, enhanced synthesis of mucopolysaccharides, and restoration of chondrocyte metabolic activity. Histological analysis revealed that SCM-treated groups exhibited reduced cartilage erosion, lower inflammatory marker expression, and improved nuclear-cytoplasmic index (NCI) values, suggesting enhanced chondrocyte function. Notably, the group with estrogen receptor blockade responded more favorably to SCM treatment than the non-blocked OA group, highlighting the potential interaction between hormonal status and epigenetic reprogramming. These findings provide strong evidence for the feasibility of epigenetic modulation as a therapeutic strategy for OA. The ability of SCMs to restore cartilage structure and function suggests a novel approach to treating age-related degenerative diseases. Further research is required to elucidate the precise molecular mechanisms underlying this rejuvenation process and optimize therapeutic protocols for clinical applications.
- Open Access
- 4 September 2024
- Published by UK Scientific Publishing Limited in Trends in Immunotherapy
- Vol. 8 (2) , 6451
Revisiting immunology textbooks: Considering potential insights based on the role of RNA-guided antiviral defense
Amidst the COVID-19 pandemic, this article offers a cautious re-evaluation of traditional notions surrounding the immune system’s role in combating viral infections. Departing from the prevalent emphasis on antibodies and T cells, the manuscript proposes a hypothesis highlighting the pivotal role of RNA interference present in every nucleated cell of the human body for antiviral defense. This system, honed over years of co-evolution with viruses, harbors a diverse array of microRNAs aimed at suppressing viral replication. Additionally, in the event of failure, novel microRNAs are synthesized to target specific viruses, underscoring the concept of natural immunity and RNA interference’s adaptability. Delving into the sentinel role of the specialized immune system (SIS), the article underscores its significance in safeguarding the body’s integrity and combating tumors, extending beyond mere adaptation to pathogens. It also discusses the risks associated with antibody-dependent enhancement of infection and the depletion of naive T and B cells resulting from extensive use of antiviral vaccines. By accentuating the significance of RNA interference as an often-overlooked aspect of human antiviral defenses, the authors advocate for broader, more exploratory discussions within the scientific community regarding the intricate nature of immune responses and vaccine efficacy.
- 4 September 2024
- Published by UK Scientific Publishing Limited in Trends in Immunotherapy
- Vol. 8 (2) , 6451
Open AccessRevisiting immunology textbooks: Considering potential insights based on the role of RNA-guided antiviral defense
Amidst the COVID-19 pandemic, this article offers a cautious re-evaluation of traditional notions surrounding the immune system’s role in combating viral infections. Departing from the prevalent emphasis on antibodies and T cells, the manuscript proposes a hypothesis highlighting the pivotal role of RNA interference present in every nucleated cell of the human body for antiviral defense. This system, honed over years of co-evolution with viruses, harbors a diverse array of microRNAs aimed at suppressing viral replication. Additionally, in the event of failure, novel microRNAs are synthesized to target specific viruses, underscoring the concept of natural immunity and RNA interference’s adaptability. Delving into the sentinel role of the specialized immune system (SIS), the article underscores its significance in safeguarding the body’s integrity and combating tumors, extending beyond mere adaptation to pathogens. It also discusses the risks associated with antibody-dependent enhancement of infection and the depletion of naive T and B cells resulting from extensive use of antiviral vaccines. By accentuating the significance of RNA interference as an often-overlooked aspect of human antiviral defenses, the authors advocate for broader, more exploratory discussions within the scientific community regarding the intricate nature of immune responses and vaccine efficacy.
- Open Access
- 26 February 2024
- Published by Qeios Ltd in Qeios Preprints
Revisiting Immunology Textbooks: Considering Potential Insights Based on the Role of RNA-Guided Antiviral Defense
Amidst the backdrop of the COVID-19 pandemic, this article proposes a cautious reassessment of conventional understandings surrounding the immune system's role in combating viral infections. Departing from the prevailing focus on antibodies and T cells, the manuscript introduces a hypothesis that underscores the potential significance of RNA-mediated antiviral defense mechanisms such as CRISPR-Cas and RNA interference. Through an examination of the vertebrate specialized immune system (SIS) and interferons, the article explores the concept of antibody-dependent enhancement of infection, positioning it as a subject necessitating further investigation rather than a definitive critique of vaccination strategies. Emphasizing the importance of RNA interference as an overlooked element of human antiviral defenses, the authors advocate for a broader and more exploratory discourse within the scientific community regarding the intricate nature of immune responses and vaccine efficacy.
- 26 February 2024
- Published by Qeios Ltd in Qeios Preprints
Open AccessRevisiting Immunology Textbooks: Considering Potential Insights Based on the Role of RNA-Guided Antiviral Defense
Amidst the backdrop of the COVID-19 pandemic, this article proposes a cautious reassessment of conventional understandings surrounding the immune system's role in combating viral infections. Departing from the prevailing focus on antibodies and T cells, the manuscript introduces a hypothesis that underscores the potential significance of RNA-mediated antiviral defense mechanisms such as CRISPR-Cas and RNA interference. Through an examination of the vertebrate specialized immune system (SIS) and interferons, the article explores the concept of antibody-dependent enhancement of infection, positioning it as a subject necessitating further investigation rather than a definitive critique of vaccination strategies. Emphasizing the importance of RNA interference as an overlooked element of human antiviral defenses, the authors advocate for a broader and more exploratory discourse within the scientific community regarding the intricate nature of immune responses and vaccine efficacy.
- Open Access
- 5 December 2023
- Published by Qeios Ltd
Review of: "[Review] Dr Jekyll and Mr Hyde: From Two Branches of Immune Response to Three Types of Interferon Response"
How to interpret facts if there is no theory. I decided to write a review of the article “Dr. Jekyll and Mr. Hyde: From Two Branches of the Immune Response to Three Types of Interferon Response,” probably primarily because of the title. However, de...
- 5 December 2023
- Published by Qeios Ltd
Open AccessReview of: "[Review] Dr Jekyll and Mr Hyde: From Two Branches of Immune Response to Three Types of Interferon Response"
How to interpret facts if there is no theory. I decided to write a review of the article “Dr. Jekyll and Mr. Hyde: From Two Branches of the Immune Response to Three Types of Interferon Response,” probably primarily because of the title. However, de...
- Open Access
- 31 October 2022
- Published by SPb RAACI in Medical Immunology (Russia)
- Vol. 24 (5) , 1065-1074
RNA interference is the basis of human antiviral defense
Comparative analysis of antiviral protective mechanisms in protozoa and RNA interference of multicellular organisms has revealed their similarity, also providing a clue to understanding the adaptive immunity. In this article, we present the latest evidence on the importance of RNA-guided gene regulation in human antiviral defense. The role of neutralizing antibodies and interferon system in viral invasion is considered. The new concept has been introduced, i.e., antiviral protection of any living organism is based on the intracellular RNA-guided mechanisms. Simple and effective defense against viruses is that spacer segment of the viral DNA is inserted into the cellular chromosomes. Upon re-infection, the RNA transcript of the spacer directs nuclease enzymes against the foreign genome. This is a really adaptive immune defense that any cell potentially possesses. In humans, the interferon system provides an additional tool for early suppression of viral infections which shifts the cells to the alert regimen, thus preventing further spread of infection. The main task of the human central immune system is to maintain integrity and combat foreign organisms. Accordingly, a suitable index of acquired antiviral immunity should be a presence of specific spacer markers in DNA samples from reconvalescent persons, rather than detection of neutralizing antibodies, B and T memory cells.This article is addressed primarily to general medical community, and its practical conclusions are as follows:1. Presence or absence of specific antibodies to SARS-CoV-2 is not a prognostic sign of the disease. Detection of specific antibodies in blood simply reflects the fact that the person has contacted with the viral agent. Absence of antibodies does not mean a lack of such contact, and the persons with high titers of specific antibodies are not protected from re-infection with SARS-CoV-2.2. PCR testing: The PCR results may remain “false positive” in those subjects who have had COVID-19, if the genetic material is taken from the site of initial virus contraction (mainly, nasopharynx). In our opinion, negative PCR tests for COVID-19 in blood plasma and urine will be a more correct index for the absence of the disease, even with positive PCR tests from the nasopharyngeal samples.3. It is necessary to draw attention of general practitioners to potential usage of retinol in prevention and treatment of COVID-19, given the importance of RLR receptors in recognition of viral RNAs and positive experience of vitamin A administration in measles, another dangerous viral disease.
- 31 October 2022
- Published by SPb RAACI in Medical Immunology (Russia)
- Vol. 24 (5) , 1065-1074
Open AccessRNA interference is the basis of human antiviral defense
Comparative analysis of antiviral protective mechanisms in protozoa and RNA interference of multicellular organisms has revealed their similarity, also providing a clue to understanding the adaptive immunity. In this article, we present the latest evidence on the importance of RNA-guided gene regulation in human antiviral defense. The role of neutralizing antibodies and interferon system in viral invasion is considered. The new concept has been introduced, i.e., antiviral protection of any living organism is based on the intracellular RNA-guided mechanisms. Simple and effective defense against viruses is that spacer segment of the viral DNA is inserted into the cellular chromosomes. Upon re-infection, the RNA transcript of the spacer directs nuclease enzymes against the foreign genome. This is a really adaptive immune defense that any cell potentially possesses. In humans, the interferon system provides an additional tool for early suppression of viral infections which shifts the cells to the alert regimen, thus preventing further spread of infection. The main task of the human central immune system is to maintain integrity and combat foreign organisms. Accordingly, a suitable index of acquired antiviral immunity should be a presence of specific spacer markers in DNA samples from reconvalescent persons, rather than detection of neutralizing antibodies, B and T memory cells.This article is addressed primarily to general medical community, and its practical conclusions are as follows:1. Presence or absence of specific antibodies to SARS-CoV-2 is not a prognostic sign of the disease. Detection of specific antibodies in blood simply reflects the fact that the person has contacted with the viral agent. Absence of antibodies does not mean a lack of such contact, and the persons with high titers of specific antibodies are not protected from re-infection with SARS-CoV-2.2. PCR testing: The PCR results may remain “false positive” in those subjects who have had COVID-19, if the genetic material is taken from the site of initial virus contraction (mainly, nasopharynx). In our opinion, negative PCR tests for COVID-19 in blood plasma and urine will be a more correct index for the absence of the disease, even with positive PCR tests from the nasopharyngeal samples.3. It is necessary to draw attention of general practitioners to potential usage of retinol in prevention and treatment of COVID-19, given the importance of RLR receptors in recognition of viral RNAs and positive experience of vitamin A administration in measles, another dangerous viral disease.
- 18 February 2022
- Published by Spandidos Publications in Biomedical Reports
- Vol. 16 (4) , 1-7
Sp1A novel concept of human antiviral protection: It's all about RNA (Review)
The comparative analysis of the antiviral protective mechanisms, including protozoa and RNA interference in multicellular organisms, has revealed their similarity and provided a basic understanding of adaptive immunity. The present article summarizes the latest studies on RNA‑guided gene regulation in human antiviral protection, and its importance. Additionally, the role of both neutralizing antibodies and the interferon system in viral invasion is considered. The interferon system is an additional mechanism for suppressing viral infections in humans, which shifts cells into an ‘alarm’ mode to attempt to prevent further contagion. The primary task of the human central immune system is to maintain integrity and to protect against foreign organisms. In this review, a novel concept is proposed: Antiviral protection in all organisms can be achieved through an intracellular RNA‑guided mechanism. A simple and effective defence against viruses is incorporation of a part of a virus's DNA (spacer) into the hosts chromosomes. Following reinfection, RNA transcripts of this spacer are created to direct nuclease enzymes to destroy the viral genome. This is an example of real‑time adaptive immunity potentially possessed by every cell with a full complement of chromosomes, and an indicator that antiviral immunity is not only mediated by the presence of neutralizing antibodies and memory B‑ and T‑cells, but also by the presence of specific spacers in the DNA of individuals who have recovered from a viral infection.
- 18 February 2022
- Published by Spandidos Publications in Biomedical Reports
- Vol. 16 (4) , 1-7
Sp1A novel concept of human antiviral protection: It's all about RNA (Review)
The comparative analysis of the antiviral protective mechanisms, including protozoa and RNA interference in multicellular organisms, has revealed their similarity and provided a basic understanding of adaptive immunity. The present article summarizes the latest studies on RNA‑guided gene regulation in human antiviral protection, and its importance. Additionally, the role of both neutralizing antibodies and the interferon system in viral invasion is considered. The interferon system is an additional mechanism for suppressing viral infections in humans, which shifts cells into an ‘alarm’ mode to attempt to prevent further contagion. The primary task of the human central immune system is to maintain integrity and to protect against foreign organisms. In this review, a novel concept is proposed: Antiviral protection in all organisms can be achieved through an intracellular RNA‑guided mechanism. A simple and effective defence against viruses is incorporation of a part of a virus's DNA (spacer) into the hosts chromosomes. Following reinfection, RNA transcripts of this spacer are created to direct nuclease enzymes to destroy the viral genome. This is an example of real‑time adaptive immunity potentially possessed by every cell with a full complement of chromosomes, and an indicator that antiviral immunity is not only mediated by the presence of neutralizing antibodies and memory B‑ and T‑cells, but also by the presence of specific spacers in the DNA of individuals who have recovered from a viral infection.
- 30 November 1993
- Published by Elsevier in Zentralblatt für Bakteriologie
- Vol. 279 (4) , 494-504
Entero-Cytolysin (EC) from Vibrio cholerae Non-01 (Some Properties and Pore-Forming Activity)
- 30 November 1993
- Published by Elsevier in Zentralblatt für Bakteriologie
- Vol. 279 (4) , 494-504
Entero-Cytolysin (EC) from Vibrio cholerae Non-01 (Some Properties and Pore-Forming Activity)
- 1 October 1992
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Biomembranes
- Vol. 1111 (1) , 7-16
The mode of action of Vibrio cholerae cytolysin. The influences on both erythrocytes and planar lipid bilayers
- 1 October 1992
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Biomembranes
- Vol. 1111 (1) , 7-16
The mode of action of Vibrio cholerae cytolysin. The influences on both erythrocytes and planar lipid bilayers